Tyrosine kinase inhibitor as a novel signal transduction and antiproliferative agent: prostate cancer
- 1 March 1996
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 117 (1) , 53-58
- https://doi.org/10.1016/0303-7207(95)03725-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancerCancer and Metastasis Reviews, 1993
- Role of peptide growth factors in the prostate: A reviewUrology, 1993
- Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesisNature, 1992
- Tyrphostins—Potential antiproliferative agents and novel molecular toolsBiochemical Pharmacology, 1990
- Production of epidermal growth factor and transforming growth factor‐α by the androgen‐responsive LNCaP human prostate cancer cell lineThe Prostate, 1990
- EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGF receptor signalingCell, 1989
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988
- Androgens modulate epidermal growth factor receptor levels in the rat ventral prostateMolecular and Cellular Endocrinology, 1988
- Autocrine Stimulation of Intracellular PDGF Receptors in v- sis -Transformed CellsScience, 1988